REG-Arix Bioscience PLC Notice of Results & Investor Presentation

Arix BioscienceAnnouncement

03/08/2022 07:15

============

Arix Bioscience PLC (ARIX)
Notice of Results & Investor Presentation

03-Aug-2022 / 07:00 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

═════════════════════════════════════════════════════════════════════════════════

 

                               Arix Bioscience plc

                                         

                    Notice of Results & Investor Presentation

 

LONDON, 3 August 2022: Arix Bioscience plc (“Arix” or the “Company”) (LSE: ARIX),
a  global  venture   capital  company  focused   on  investing  in   breakthrough
biotechnology companies, will announce  its results for the  six months ended  30
June 2022 on Wednesday 10 August 2022.

 

Analyst Briefing: 9:00am, Wednesday 10 August

 

Management will host a virtual analyst presentation followed by a Q&A session  at
9:00am BST on Wednesday 10 August. Analysts wishing to join should register their
interest by contacting  1 arix@powerscourt-group.com.

 

Investor Presentation: 2:00pm, Wednesday 10 August

 

Management will be  hosting a live  presentation and Q&A  session via the  online
platform, Investor Meet Company, at 2:00pm BST on Wednesday 10 August.

 

The presentation is open to analysts and all existing and potential shareholders.
Questions can be submitted pre-event via the 'Investor Meet Company' dashboard up
until 9:00  a.m.  on  Wednesday  10  August  or  at  any  time  during  the  live
presentation. Investors  can  sign   up  to  Investor   Meet  Company  for   free
via:  2 https://www.investormeetcompany.com/arix-bioscience-plc/register-investor

 

Investors who already  follow Arix  on the  Investor Meet  Company platform  will
automatically receive an invitation to the event.

 

                                      ENDS 

 

Enquiries

For more information on Arix, please contact:

 

Arix Bioscience plc

+44 (0)20 7290 1050

ir 3 @arixbioscience.com

 

Powerscourt Group

Sarah MacLeod, Ibrahim Khalil, Nick Johnson

+44 (0)20 7250 1446

 4 arix@powerscourt-group.com

 

About Arix Bioscience plc

Arix Bioscience plc is a global  venture capital company focused on investing  in
breakthrough  biotechnology  companies  around  cutting-edge  advances  in   life
sciences.

 

We collaborate with exceptional entrepreneurs and provide the capital, expertise,
and global networks to help accelerate their ideas into important new  treatments
for patients. As  a listed company,  we are  able to bring  this exciting  growth
phase of our industry to a broader range of investors.  5 www.arixbioscience.com

 

 

═════════════════════════════════════════════════════════════════════════════════

   ISIN:           GB00BD045071
   Category Code:  NOR
   TIDM:           ARIX
   LEI Code:       213800OVT3AHQCXNIX43
   OAM Categories: 3.1. Additional regulated information required to be
                   disclosed under the laws of a Member State
   Sequence No.:   178861
   EQS News ID:    1411893


    
   End of Announcement EQS News Service

   ══════════════════════════════════════════════════════════════════════════

    6 fncls.ssp?fn=show_t_gif&application_id=1411893&application_name=news&site_id=reuters9

References

   Visible links
   1. mailto:arix@powerscourt-group.com
   2. https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=379a833b86464142ee793f69a856a65d&application_id=1411893&site_id=reuters9&application_name=news
   3. mailto:charlotte@arixbioscience.com
   4. mailto:arix@powerscourt-group.com
   5. https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=889c637ce21c3a47a35c39202ebd9825&application_id=1411893&site_id=reuters9&application_name=news


============